Morgan Stanley
MHUA

Morgan Stanley’s Meihua International Medical Technologies MHUA Stock Holding History

Morgan Stanley’s Portfolio MHUA Stock Details MHUA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28
Closed -$934 – 8213
2025
Q1 		$934 Hold
28
– – ﹤0.01% 7289
2024
Q4 		$961 Hold
28
– – ﹤0.01% 7279
2024
Q3 		$2.84K Hold
28
– – ﹤0.01% 7059
2024
Q2 		$2.37K Hold
28
– – ﹤0.01% 7037
2024
Q1 		$2.06K Sell
28
-28
-50% -$2.48K ﹤0.01% 7065
2023
Q4 		$8.25K Buy
56
+28
+100% +$5.14K ﹤0.01% 6880
2023
Q3 		$4.93K Hold
28
– – ﹤0.01% 6920
2023
Q2 		$7.94K Buy
28
+17
+155% +$6K ﹤0.01% 6886
2023
Q1 		$7.11K Buy
+11
New +$18.2K ﹤0.01% 6977

Other funds holding MHUA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley's MHUA Position: Q2 2025 in Review

Morgan Stanley sold out of Meihua International Medical Technologies (MHUA) in Q2 2025, closing a stake of 28 shares — an estimated $934 sold.

Morgan Stanley first reported a position in MHUA in Q1 2023 and held it in 9 quarters. The position peaked at $8.25K in Q4 2023. 5 funds tracked by Wall St. Rank hold MHUA as of Q2 2025.

  • Morgan Stanley reported no remaining Meihua International Medical Technologies position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 28 Meihua International Medical Technologies shares in Q2 2025, an estimated $934.
  • Morgan Stanley first reported a position in Meihua International Medical Technologies in Q1 2023 and held it in 9 quarters.
  • Morgan Stanley's Meihua International Medical Technologies position peaked at $8.25K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.